BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 18, 2004
View Archived Issues
Antiangiogenic small molecule inhibits VEGF production in tumors in vivo
Read More
Turmeric extract prevents arthritis in rat model
Read More
Pharmacokinetic profile of novel bone resorption inhibitor
Read More
Nucleotide-bisphosphonate conjugates reduce metastatic bone tumor burden in mice
Read More
Novel vasopressin V1a receptor antagonists and their use in dysmenorrhea
Read More
New analgesic vanilloid VR1 antagonists discovered at Merck
Read More
Antagonists of denatured collagen type IV and their use as antiangiogenic agents
Read More
Novel PPAR agonists and their use described by Pfizer researchers
Read More
Neurogen presents novel GABA-A receptor modulators
Read More
New benzofurans acting as 5-HT reuptake inhibitors and 5-HT receptor ligands
Read More
New indole-containing oxazolidinone antibacterial agents identified at Pfizer
Read More
Highlights from the 4th Annual Biotech In Europe Investor Forum now available at LifeSciChannel.com
Read More
Anecortave acetate study results
Read More
R&D highlights from the 4th Annual Biotech In Europe Investor Forum: BioTie Therapies
Read More
ArQule discovers oral B-RAF kinase inhibitors for oncology
Read More
CuraGen advances CR-011 for metastatic melanoma
Read More
Cerovive phase III trials to continue
Read More
Visudyne VIO study recommended to continue
Read More
IND submission for Syrrx-designed DPP IV inhibitor for diabetes
Read More
Enrollment opens in phase II study of MX-3253
Read More
JuvImmune platform to be tested in PuntaToro virus infection model
Read More
Patients receive HGS-ETR1 in new cancer studies
Read More
AGIX-4207 discontinued for rheumatoid arthritis after disappointing results
Read More
Pivotal PolyHeme study cleared to continue
Read More
R&D highlights from the 4th Annual Biotech In Europe Investor Forum: BioXell
Read More
Vantas approved for advanced prostate cancer
Read More
Government funding for Elusys' development of anthrax antibody treatment
Read More
Abarelix demonstrates safety and efficacy in clinical trials
Read More
New data on the antimicrobial activity and pharmacokinetics of tigecycline
Read More
HepeX-C reduces viral levels in patients with chronic HCV infection
Read More
Bone turnover has no effect on the benefits of teriparatide in women with osteoporosis
Read More
Update on the pharmacokinetic profile of a transdermal PTH formulation
Read More
